D.E. Shaw & Co’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-408,574
| Closed | -$4.13M | – | 3824 |
|
|
2022
Q4 | $4.13M | Buy |
408,574
+150,000
| +58% | +$1.52M | ﹤0.01% | 1575 |
|
|
2022
Q3 | $2.57M | Buy |
258,574
+400
| +0.2% | +$3.97K | ﹤0.01% | 1955 |
|
|
2022
Q2 | $2.53M | Hold |
258,174
| – | – | ﹤0.01% | 2106 |
|
|
2022
Q1 | $2.52M | Sell |
258,174
-135,985
| -35% | -$1.32M | ﹤0.01% | 2267 |
|
|
2021
Q4 | $3.82M | Buy |
394,159
+165,129
| +72% | +$1.6M | ﹤0.01% | 1909 |
|
|
2021
Q3 | $2.22M | Buy |
229,030
+195,697
| +587% | +$1.89M | ﹤0.01% | 2036 |
|
|
2021
Q2 | $322K | Buy |
+33,333
| New | +$322K | ﹤0.01% | 3065 |
|